Radiologic evaluation of prophylaxis in severe haemophilia.
about
Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or BIL-6 receptor antagonist as adjunctive therapy with clotting factor replacement to protect against bleeding-induced arthropathy in hemophiliaIsotopic synovectomy with P-32 in paediatric patients with haemophilia.A modeling approach to evaluate long-term outcome of prophylactic and on demand treatment strategies for severe hemophilia A.Management of haemophilic arthropathy.Pathophysiology, diagnosis and prevention of arthropathy in patients with haemophilia.Recommendations for assessment, monitoring and follow-up of patients with haemophilia.Models of prophylaxis.The burden of bleeding in haemophilia: is one bleed too many?Advancing personalized care in hemophilia A: ten years' experience with an advanced category antihemophilic factor prepared using a plasma/albumin-free method.Outcome measures in haemophilia: a systematic review.Assessing health-related quality-of-life in individuals with haemophilia.Rapid rFVIIa enhanced on-demand dosing in haemophilia inhibitor patients.Promoting self-management and adherence during prophylaxis: evidence-based recommendations for haemophilia professionals.Long-term effects of joint bleeding before starting prophylaxis in severe haemophilia.Choosing outcome assessment tools in haemophilia care and research: a multidisciplinary perspective.Clinical outcomes and patient satisfaction following total joint replacement in haemophilia--23-year experience in knees, hips and elbows.Evaluating outcome of prophylaxis in haemophilia: objective and self-reported instruments should be combined.Health-Related Quality of Life and Association With Arthropathy in Greek Patients with Hemophilia.Comparison of ultrasound and magnetic resonance imaging for diagnosis and follow-up of joint lesions in patients with haemophilia.Using the Haemophilia Joint Health Score for assessment of teenagers and young adults: exploring reliability and validity.The association of haemophilic arthropathy with Health-Related Quality of Life: a post hoc analysis.A calculator program for individualizing factor VIII dosage.Epidemiological survey of the orthopaedic status of severe haemophilia A and B patients in France. The French Study Group. secretariat.haemophiles@cch.ap-hop-paris.fr.Computed tomography in hemophilic pseudotumor.The orthopaedic status of severe haemophiliacs in Spain.Inter- and intra-observer reliability of radiographic scores commonly used for the evaluation of haemophilic arthropathy.Long-term outcome of individualized prophylactic treatment of children with severe haemophilia.Validity of health status measurement with the Dutch Arthritis Impact Measurement Scale 2 in individuals with severe haemophilia.Changes in treatment strategies for severe haemophilia over the last 3 decades: effects on clotting factor consumption and arthropathy.Prophylactic therapy for hemophilia in a developing country, Turkey.Discontinuation of prophylactic therapy in severe haemophilia: incidence and effects on outcome.Aspects of haemophilia prophylaxis in Sweden.Results of an orthopaedic survey in young patients with severe haemophilia in Spain.Secondary prophylaxis vs. on-demand treatment to improve quality of life in severe adult haemophilia A patients: a prospective study in a single centre.
P2860
Q24234413-80415383-0DB6-4B14-ADEC-78E7B5A966ADQ30439206-541784B3-6700-4ABE-8E18-AB48E5364AC5Q34049937-C4484E77-6A6A-40FE-8704-F15B40946AC8Q34890523-3F271572-9B7C-48AD-9983-71798B19199FQ37169665-BFFDAD36-4180-4722-ACE9-5E47F878DF3EQ37845930-873E6370-70EB-445E-B05A-1D811E327698Q37944947-D721A7A9-2D63-4A68-97DA-576F03885011Q38020979-009DB1CE-3298-48B1-BB0B-5DB9D4DB03A5Q38182702-2B3AAE29-DE3D-4B59-ABC4-B6D6C01A4F07Q38205211-4A8D96F4-9FD3-4AC3-BF8A-E668AB6CD0B3Q38222571-B25E6B9B-6597-45F5-8AC5-C6FD745482CEQ38498570-246D6D32-D2BB-45D5-974A-8CB0ECE51806Q38546790-0D377567-1A5B-4588-B971-205AB4CB28C0Q38807701-C63B4EC2-161B-4E82-9903-628D66D1A920Q38843540-8D0B98F9-E4ED-4B79-9DE1-D739CE7C0A4BQ38955500-9F17BD8D-8432-4D93-A3B1-57A54FE34540Q39264672-BB23BC52-DC02-4718-8681-85BB12771590Q40013630-B1B4C4C0-3018-4EF0-AE5A-3CB68E81AA72Q42695890-25271D9C-5A5B-4748-BBDB-D5E652C0CF41Q43527709-D2D79F33-6F46-4832-BCDA-4853D3ACF2ECQ44184274-B9443EC0-2200-4639-B469-34102360C2D5Q45861291-6A715B90-A8DA-4283-98E0-AF591F7474E8Q45862684-F3689EA2-D619-499E-BFAC-6AC9AC628C22Q45864545-D14A1C2B-5493-4245-A7C4-ED40159F5B67Q45865274-12DE9E73-B24F-479A-9B60-EE08F608209FQ45867244-0640964D-D0EB-4570-930B-D7A4CAA560CBQ45874693-80AEF1ED-C02F-4970-A967-CCD6697B0C2CQ45875796-E73616DB-47FB-477C-A92B-6C4BE51A2A57Q45875842-D10D7485-5B26-4E27-92F9-791C3A7304ADQ45879749-EFA8D952-54E0-4D77-9D13-26564DC87AABQ45881201-AFF510DB-AAB2-486E-AB45-C882D72E277FQ45883466-92DAF612-5A8B-4B13-9B90-0895D7E1D3D5Q45885381-F19E83FF-EE38-4476-9A5E-BDF0FB2564BDQ45885387-49C4D92F-82A5-45B4-90B3-0926BF648F66Q45888597-376E9B0B-E734-4EFA-92DB-F74D8498F8A2
P2860
Radiologic evaluation of prophylaxis in severe haemophilia.
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年学术文章
@wuu
1981年学术文章
@zh
1981年学术文章
@zh-cn
1981年学术文章
@zh-hans
1981年学术文章
@zh-my
1981年学术文章
@zh-sg
1981年學術文章
@yue
1981年學術文章
@zh-hant
name
Radiologic evaluation of prophylaxis in severe haemophilia.
@en
Radiologic evaluation of prophylaxis in severe haemophilia.
@nl
type
label
Radiologic evaluation of prophylaxis in severe haemophilia.
@en
Radiologic evaluation of prophylaxis in severe haemophilia.
@nl
prefLabel
Radiologic evaluation of prophylaxis in severe haemophilia.
@en
Radiologic evaluation of prophylaxis in severe haemophilia.
@nl
P2093
P2860
P1476
Radiologic evaluation of prophylaxis in severe haemophilia.
@en
P2093
P2860
P304
P356
10.1111/J.1651-2227.1981.TB05741.X
P577
1981-07-01T00:00:00Z